Catalent, Inc. Announces Second Quarter Fiscal Year 2015 Earnings Conference Webcast
22 Januar 2015 - 10:06PM
Business Wire
Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global
provider of advanced delivery technologies and development
solutions for drugs, biologics and consumer health products, today
announced that it will release financial results for the second
quarter of fiscal year 2015 ended December 31, 2014 after the
market close on Wednesday, February 11, 2015. The Company’s
management will host a webcast to discuss the results at 4:30 p.m.
ET on the same day.
Catalent invites all interested parties to listen to the
webcast, which will be accessible through Catalent’s website at
http://investor.catalent.com.
A supplemental slide presentation will also be available in the
Investors section of Catalent’s website prior to the start of the
webcast.
The webcast replay, along with the supplemental slides, will be
available for 90 days in the Investors section at
www.catalent.com.
About Catalent, Inc.
Catalent, Inc. (NYSE:CTLT) is the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products. With over 80 years serving
the industry, Catalent has proven expertise in bringing more
customer products to market faster, enhancing product performance
and ensuring reliable clinical and commercial product supply.
Catalent employs approximately 8,000 people, including over 1,000
scientists, at nearly 30 facilities across 5 continents and in
fiscal 2014 generated more than $1.8 billion in annual revenue.
Catalent is headquartered in Somerset, N.J. For more information,
please visit www.catalent.com.
Forward-Looking Statements
This press release contains both historical and forward-looking
statements. All statements other than statements of historical fact
are, or may be deemed to be, forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements generally can be identified by the
use of statements that include phrases such as “believe,” “expect,”
“anticipate”, “intend”, “estimate”, “plan”, “project”, “foresee”,
“likely”, “may”, “will”, “would” or other words or phrases with
similar meanings. Similarly, statements that describe our
objectives, plans or goals are, or may be, forward-looking
statements. These statements are based on current expectations of
future events. If underlying assumptions prove inaccurate or
unknown risks or uncertainties materialize, actual results could
vary materially from our expectations and projections. Some of the
factors that could cause actual results to differ include, but are
not limited to, the following: general industry conditions and
competition; product or other liability risk inherent in the
design, development, manufacture and marketing of our offerings;
inability to enhance our existing or introduce new technology or
services in a timely manner; economic conditions, such as interest
rate and currency exchange rate fluctuations; technological
advances and patents attained by competitors; our substantial debt
and debt service requirements, which restrict our operating and
financial flexibility and impose significant interest and financial
costs; the consequences of operating in a highly regulated
environment; and difficulty in integrating new acquisitions into
our existing business, thereby reducing or eliminating the
anticipated benefits of the transactions. For a more detailed
discussion of these and other factors, see the information under
the caption “Risk Factors” in our Annual Report on Form 10-K for
the fiscal year ended June 30, 2014 filed with the Securities and
Exchange Commission. All forward-looking statements in this release
speak only as of the date of this release or as of the date they
are made, and we do not undertake to update any forward-looking
statement as a result of new information or future events or
developments unless and only to the extent required by law.
More products. Better treatments. Reliably
supplied.™
Investors:For CatalentJeremy Feffer,
732-537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024